Evidence map›Paper›PMID 34795764›Full record

ReviewStem cells international2021

Classification and Characteristics of Mesenchymal Stem Cells and Its Potential Therapeutic Mechanisms and Applications against Ischemic Stroke.

Pian Gong, Wei Zhang, Yan He, Jianfeng Wang, Song Li, Songyu Chen, Qingsong Ye, Mingchang Li

Open access · goldAbstract readReview
In one paragraph

Review in Stem cells international, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Application of autophagy in mesenchymal stem cells.World journal of stem cells · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Pian GongDepartment of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, China.
Wei ZhangDepartment of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, China.
Yan HeRegenerative Medicine Lab, Tianyou Hospital, Wuhan University of Science and Technology, Wuhan, Hubei 430064, China.
Jianfeng WangDepartment of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, China.
Song LiDepartment of Neurosurgery, Shanghai Tenth People's Hospital, Tongji University, Shanghai, China.
Songyu ChenDepartment of Neurosurgery, Shanghai Tenth People's Hospital, Tongji University, Shanghai, China.
Qingsong YeCenter of Regenerative Medicine, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, China.ORCID https://orcid.org/0000-0002-2868-9247
Mingchang LiDepartment of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, China.ORCID https://orcid.org/0000-0003-4019-8886
Wuhan University · CNTongji University · CNWuhan University of Science and Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ischemic stroke is a serious cerebral disease that often induces death and long-term disability. As a currently available therapy for recanalization after ischemic stroke, thrombolysis, including intravenous thrombolysis and endovascular therapy, still cannot be applicable to all patients due to the narrow time window. Mesenchymal stem cell (MSC) transplantation therapy, which can trigger neuronal regeneration and repair, has been considered as a significant advance in treatment of ischemic stroke. MSC transplantation therapy has exhibited its potential to improve the neurological function in ischemic stroke. Our review describes the current progress and future perspective of MSC transplantation therapy in ischemic stroke treatment, including cell types, transplantation approaches, therapeutic mechanisms, and preliminary clinical trials of MSC transplantation, for providing us an update role of MSC transplantation in ischemic stroke treatment.

Identifiers

PMID34795764
PMCPMC8595011
OpenAlexW3212186332

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.